A Phase I, Single-Center, Open-Label, Non-Randomized, One-Sequence Crossover, Pharmacokinetic Interaction Study of the Combination Product VI-0521 (Phentermine Plus Topiramate) With Metformin, Sitagliptin or Probenecid in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Jan 2010
At a glance
- Drugs Metformin; Phentermine/topiramate; Probenecid; Sitagliptin
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors VIVUS
- 21 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Feb 2009 New trial record